These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 29289609)

  • 41. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
    Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
    Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer.
    Liu K; Chen HL; Gu MM; You QS
    Int J Clin Exp Pathol; 2015; 8(12):16081-8. PubMed ID: 26884885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.
    Xu TP; Shen H; Liu LX; Shu YQ
    Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC).
    Azad AK; Qiu X; Boyd K; Kuang Q; Emami M; Perera N; Palepu P; Patel D; Chen Z; Cheng D; Feld R; Leighl NB; Shepherd FA; Tsao MS; Xu W; Liu G; Cuffe S
    Lung Cancer; 2014 Jun; 84(3):289-94. PubMed ID: 24679952
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer.
    Zhao W; Hu L; Xu J; Shen H; Hu Z; Ma H; Shu Y; Shao Y; Yin Y
    Cancer Chemother Pharmacol; 2013 May; 71(5):1287-95. PubMed ID: 23479135
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-related single-nucleotide polymorphism of XPO5 is strongly correlated with the prognosis and chemotherapy response in advanced non-small-cell lung cancer patients.
    Geng JQ; Wang XC; Li LF; Zhao J; Wu S; Yu GP; Zhu KJ
    Tumour Biol; 2016 Feb; 37(2):2257-65. PubMed ID: 26358254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
    Kalikaki A; Kanaki M; Vassalou H; Souglakos J; Voutsina A; Georgoulias V; Mavroudis D
    Clin Lung Cancer; 2009 Mar; 10(2):118-23. PubMed ID: 19362955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic variants of CHEK1, PRIM2 and CDK6 in the mitotic phase-related pathway are associated with nonsmall cell lung cancer survival.
    Mu R; Liu H; Luo S; Patz EF; Glass C; Su L; Du M; Christiani DC; Jin L; Wei Q
    Int J Cancer; 2021 Sep; 149(6):1302-1312. PubMed ID: 34058013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potentially functional polymorphisms in DNA repair genes and non-small-cell lung cancer survival: a pathway-based analysis.
    Dong J; Hu Z; Shu Y; Pan S; Chen W; Wang Y; Hu L; Jiang Y; Dai J; Ma H; Jin G; Shen H
    Mol Carcinog; 2012 Jul; 51(7):546-52. PubMed ID: 21739480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.
    Lee Y; Yoon KA; Joo J; Lee D; Bae K; Han JY; Lee JS
    Carcinogenesis; 2013 Feb; 34(2):307-13. PubMed ID: 23144319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expression.
    Bartolucci R; Wei J; Sanchez JJ; Perez-Roca L; Chaib I; Puma F; Farabi R; Mendez P; Roila F; Okamoto T; Taron M; Rosell R
    Clin Lung Cancer; 2009 Jan; 10(1):47-52. PubMed ID: 19289372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel genetic variants in HDAC2 and PPARGC1A of the CREB-binding protein pathway predict survival of non-small-cell lung cancer.
    Tang D; Zhao YC; Qian D; Liu H; Luo S; Patz EF; Moorman PG; Su L; Shen S; Christiani DC; Glass C; Gao W; Wei Q
    Mol Carcinog; 2020 Jan; 59(1):104-115. PubMed ID: 31713888
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of ATG10 expression quantitative trait loci in non-small cell lung cancer survival.
    Xie K; Liang C; Li Q; Yan C; Wang C; Gu Y; Zhu M; Du F; Wang H; Dai J; Liu X; Jin G; Shen H; Ma H; Hu Z
    Int J Cancer; 2016 Oct; 139(7):1564-73. PubMed ID: 27225307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variations within 3'-UTR of MDM4 gene contribute to clinical outcomes of advanced non-small cell lung cancer patients following platinum-based chemotherapy.
    Yang Y; Gao W; Ding X; Xu W; Liu D; Su B; Sun Y
    Oncotarget; 2017 Mar; 8(10):16313-16324. PubMed ID: 27462918
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population.
    Jin G; Miao R; Hu Z; Xu L; Huang X; Chen Y; Tian T; Wei Q; Boffetta P; Shen H
    Int J Cancer; 2009 May; 124(9):2172-8. PubMed ID: 19132754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polymorphisms of key chemokine genes and survival of non-small cell lung cancer in Chinese.
    Ma H; Shu Y; Pan S; Chen J; Dai J; Jin G; Hu Z; Shen H
    Lung Cancer; 2011 Nov; 74(2):164-9. PubMed ID: 21514686
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin polymorphisms associated with overall survival, disease-free survival, and recurrence in non-small cell lung cancer patients.
    Woods NT; Monteiro AN; Thompson ZJ; Amankwah EK; Naas N; Haura EB; Beg AA; Schabath MB
    Mol Carcinog; 2015 Jun; 54 Suppl 1(0 1):E172-84. PubMed ID: 25597281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of Cystatin SN significantly correlates with recurrence, metastasis, and survival duration in surgically resected non-small cell lung cancer patients.
    Cao X; Li Y; Luo RZ; Zhang L; Zhang SL; Zeng J; Han YJ; Wen ZS
    Sci Rep; 2015 Feb; 5():8230. PubMed ID: 25648368
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
    Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
    Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polymorphisms in cancer-related pathway genes and lung cancer.
    Lee SY; Kang HG; Choi JE; Jung DK; Lee WK; Lee HC; Lee SY; Yoo SS; Lee J; Seok Y; Lee EB; Cha SI; Cho S; Kim CH; Lee MH; Park JY
    Eur Respir J; 2016 Oct; 48(4):1184-1191. PubMed ID: 27587543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.